That protection is real and clinically meaningful, but it's upstream of DPC function rather than directly activating it
Slominski AT, Broyna AA, Zmijewski MA, Janjetovic Z, Kim T-K, Slominski RM, et al
What they found: Cagrilintide 4.5 mg: 10.8 % weight reduction vs 3.0 % placebo (p 40 % of patients achieved 25 % weight reduction , historically unprecedented Safety profile in line with Phase 2 data Why it matters: REDEFINE 1 confirmed CagriSema as the largest body-weight signal reported in the published incretin literature to date
Career journey and experience Tavishi began her health journalism journey in 2017, and has since reported for RSTV, Financial Express, Jagran, HT Media Labs and Zee
Antibody-dependent cellular cytotoxicity Infected cells complexed with antibody can be killed by ADCC (Fig
The goal is identifying and treating the underlying condition causing the elevation